Healthcare | October 13, 2021
Supreem Pharma launches its superfoods division
It has planned an investment of over Rs 80 crore in the next five years
It has planned an investment of over Rs 80 crore in the next five years
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
The company plans to raise US $ 15 million
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
Since its inception, the company has either acquired or taken a majority stake in five companies
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
AZD7442 reduced risk of developing severe Covid-19 or death in Tackle Phase III outpatient treatment trial
Subscribe To Our Newsletter & Stay Updated
